Documente Academic
Documente Profesional
Documente Cultură
Endometriosis
Case 1
A 20 y.o. woman presents to her
gynecologist with a 4 year history of
increasing lower abdominal pain with her
menses. The pain begins on the first day of
her menses and lasts 2-3 days. She also
complains of lower back pain and nausea.
Menarche occurred at the age of 13 and her
menses occur every 28 days and last 5 days.
Physical and pelvic exam are normal.
Case 1
How is dysmenorrhea diagnosed? How is it
distinguished from other types of pelvic
pain?
What is the pathophysiology of
dysmenorrhea?
What are reasonable approaches to
treatment?
Dysmenorrhea
Dysmenorrhea severe, painful cramping
sensation in the lower abdomen often accompanied
by other symptoms sweating, tachycardia,
headaches, n/v, diarrhea, tremulousness, all
occurring just before or during menses
- Primary: no obvious pathologic condition, onset
< 20 years old
- Secondary: associated with pelvic conditions or
pathology
Primary Dysmenorrhea
Pathogenesis: elevated PG F2 in secretory
endometrium (increased uterine
contractility)
Treatment: NSAIDs PG synthetase
inhibitors 1st line treatment of choice
Other treatment options: OCPs, other
analgesics
Secondary Dysmenorrhea
Etiologies
- Cervical Stenosis
- Endometriosis and Adenomyosis
- Pelvic Infection
- Adhesions
- Pelvic Congestion
- Stress and Tension
Secondary Dysmenorrhea
Cervical Stenosis
- Severe narrowing of cervical canal may
impede menstrual outflow congenital or
iatrogenic
- can cause an increase in intrauterine
pressure during menses
- can lead to endometriosis
Secondary Dysmenorrhea
Cervical Stenosis
- Hx scant menstrual flow, severe
cramping throughout menses
- Dx inability to pass a thin probe through
the internal os OR HSG demonstrates thin
cx canal
- Tx cervical dilation via D&C or
laminaria placement
Secondary Dysmenorrhea
Pelvic Congestion
- Due to engorgement of pelvic vasculature
- Hx burning or throbbing pain, worse at
night and after standing
- Dx Laparoscopic visualization of
engorgement/varicosities of broad ligament
and pelvic sidewall veins
Case 1
At the age of 30, the patient presents with a 2 year
history of infertility. Her menses are still regular
but she has 2-3 days of spotting before her menses
are due. She also complains of pain with
intercourse and pelvic pain. In reviewing the
patients history, the gynecologist notes that over
the past year the patient was repeatedly treated by
her internist with antibiotics for recurrent
microscopic hematuria.
Case 1
What is the most likely diagnosis?
What are the main theories regarding the
pathogenesis in this case?
How would you evaluate and treat this
patient?
Endometriosis - Symptoms
Variable and unpredictable
- asymptomatic
- dysmenorrhea
- CPP
- deep dyspareunia
- sacral backache w/ menses
- dysuria +/- hematuria (bladder involvement)
- dyschezia/hematochezia (bowel involvement)
Endometriosis - Incidence
Endometriosis - Pathogenesis
Retrograde menstruation (Sampson)
Hematogenous or lymphatic spread
(Halban)
Coelomic metaplasia (Meyer/Novack)
Iatrogenic dissemination
Immunologic defects (Dmowski)
Genetic predisposition
Endometriosis - Pathogenesis
Retrograde menstruation (Sampsons theory)
- Monkey experiments sutured cervix closed to
create outflow obstruction caused development
of endometriosis
- Clinical observation of retrograde menstrual flow
during laparoscopy in humans
- Increased risk of endometriosis in women with
cervical/vaginal atresia, other outflow obstruction
- Increased risk with early menarche, longer and
heavier flow
- Decreased risk with decreased estrogen levels
e.g. exercise-induced menstrual disorders,
decreased body fat, + tobacco use
Endometriosis - Pathogenesis
Hematogenous or lymphatic spread
- Endometriosis found in remote sites lung, nose,
spinal cord, pelvic lymph nodes.
Endometriosis - Pathogenesis
Coelomic metaplasia
- Mullerian ducts are derived from coelomic
epithelium during fetal development
- Hypothesize that coelomic epithelium retains
ability for multipotential development
- Endometriosis seen in prepubertal girls, women
w/ congenital absence of the uterus, and RARELY
in men
Endometriosis - Pathogenesis
Iatrogenic dissemination
- Endometriosis has been found in cesarean
section scar
Immunologic defects
Genetic predisposition
- polygenic, multi-factorial
Endometriosis - Diagnosis
Laparoscopy with biopsy proven histologic
diagnosis standard for dx of endometriosis
Empiric medical treatment with improvement in
symptoms
CA 125 NOT considered to be of clinical utility
Imaging US, MRI, CT only useful in the
presence of pelvic or adnexal masses
(endometriomas)
Endometriosis - Diagnosis
Laparoscopy with biopsy proven histologic
diagnosis standard for dx of endometriosis
- Extent of visible lesions do not correlate with
severity of sx, but depth of infiltration of lesions
seems to correlate best with pain severity
- classic powder-burn lesions, endometriomas
- lesions can be red, clear or white more
commonly seen in adolescents
Endometriosis - Diagnosis
Endometriosis - Diagnosis
Endometrial epithelium
Endometrial glands
Endometrial stroma
Hemosiderin-laden macrophages
Endometriosis - Diagnosis
Imaging US, MRI, CT only useful in the
presence of pelvic or adnexal masses
(endometriomas)
- on US, endometriomas appear as cysts that
contain low-level homogeneous internal
echoes consistent with old blood (ddx
includes hemorrhagic cysts)
Endometriosis - Diagnosis
Endometriosis - Treatment
Medications
- Progestins
- OCPs continuous vs. cyclic if no relief in 3
months, consider tx with Depo Provera or GnRH
agonist
- NSAIDs
- GnRH agonists most expensive
- Danazol appears to be as effective as GnRH
agonist for pain relief but with increased sideeffects
Endometriosis - Treatment
GnRH agonists create a state of relative
estrogen deficiency vasomotor side effects
and potential decrease in bone density
- 12-month course of GnRH agonist therapy
associated with 6% decrease in bone density
- No data regarding extended treatment with
GnRH agonists beyond 1 year
Endometriosis - Treatment
Add-back therapy is advocated for women
undergoing long-term therapy (i.e. > 6 months)
Some evidence to suggest that immediate addback therapy may result in even less bone loss
- Add-back regimens: progestins alone, progestins
+ bisphosphonates, low-dose progestins +
estrogens, pulsatile PTH
Endometriosis Treatment
Considerations in Adolescents
GnRH treatment is NOT recommended for
patients < 18 years because the effects of
these medications on bone formation and
long-term bone density have not been
adequately studied
Depo provera used for longer than 2 years
has been shown to decrease bone density in
adolescents FDA warning against longterm use
Endometriosis Treatment
Considerations in Adolescents
If no improvement in symptoms after 3
months of empiric treatment with NSAIDs
and OCPs, diagnostic laparoscopy should
be offered
Endometriosis - Treatment
Surgery
- Laparoscopic laser vaporization vs.
cauterization vs. excision
- Ovarian cystectomy for endometrioma
- Hysterectomy +/- BSO
Endometriosis - Treatment
Medications vs. Surgery
- Lack of data to support surgery vs. medical
treatment for tx of pain symptoms due to
endometriosis
- Starting with empiric medical therapy is
appropriate
- Offer GnRH agonist therapy if initial medical
treatment with OCPs and NSAIDs not helping
- Cost of comparing empiric medical management
with definitive surgical diagnosis is difficult to
assess, but 3 months of empiric treatment is less
than a laparoscopic procedure
Endometriosis - Treatment
Medications vs. Surgery
- Surgery is associated with significant
decrease in pain sx during the 1st 6 months
following surgery
- Approximately 40% experience recurrent
symptoms within 1 yr post-op
- Cumulative 5-yr recurrence rate of pain sx
after d/c GnRH tx is ~50%
Endometriosis - Treatment
Medications vs. Surgery
- No evidence exists regarding effectiveness of
adjunctive tx w/ danazol, OCPs, or progestins
post-op in comparison with surgical treatment
alone in the management of endometriosis-related
pain
- However, 2 studies suuport the use of post-op
GnRH agonists to extend the period of pain relief
post-op
Case 2
A 35 y.o. woman presents to your office
with persistent RLQ pain. Her past medical
history is unremarkable with the exception
of a ruptured appendix 1 year ago requiring
emergency surgery. Her abdominal and
pelvic exams are also unremarkable with
the exception of a well-healed
appendectomy scar.
Case 2
What questions would be important to ask
in evaluating the patient?
What is the most likely diagnosis?
How would you treat this patient?
Pelvic Pain
Pain is always subjective
Chronic Pelvic Pain (CPP) non-cyclic pain
of 6 or more months duration that localizes
to the anatomic pelvis, anterior abdominal
wall at or below the umbilicus, the
lumbosacral back, or the buttocks and is of
sufficient severity to cause functional
disability or lead to medical care
Pelvic Pain
Approximately 15-20% of women aged 18-50
years have CPP of greater than 1 years duration
20-50% of women who receive care in primary
care practices have > 1 diagnosis
Demographic profiles suggest no difference in
woman w/ CPP compared to women w/o CPP in
terms of age, race and ethnicity, education,
socioeconomic status, or employment status
Case 3
A 28 y.o. woman presents with a 6 hour
history of severe RLQ pain, which began
suddenly on arising from bed. Since the
pain began, she has been nauseated and
vomited twice. She reports two other
episodes of similar pain in the past week,
both of which resolved within 30 minutes.
Case 3
What other history would you find helpful?
How would the physical exam findings
assist you with your differential diagnosis?
What diagnostic tests would you order?
What is your differential diagnosis?